Following a description of the epidemiology and microbial etiology of ambulatory and hospitalized Community-Acquired Pneumonia, this book presents a review of the important advances in therapeutics, including drug resistance of the three major classes of antibiotics used for its treatment: betalactams, macrolides and quinolones.

This book picks up on guideline recommendations and presents a balanced analysis to help physicians comply with the requirement for the highest standard of care. In addition, the authors provide an insight into the 10 per cent of patients that do not respond to antibiotics and could benefit from adjunctive therapies, some still under review. This volume will be welcomed by pulmonologists and all clinicians involved in managing community-acquired pneumonia.

ContentsPrefaceList of Contributors1 Epidemiology of Community-Acquired Pneumonia OutsideHospitalTheo JM Verheij2 Epidemiology of Adult Hospitalized Community-AcquiredPneumoniaMark Woodhead3 Microbial Aetiology and Antibiotic Resistances inCommunity-Acquired PneumoniaGerard Huchon4 Microbiological Diagnosis of Community-Acquired PneumoniaMargareta Ieven5 Empirical Treatment of Community-Acquired Pneumonia:Current GuidelinesJavier Aspa, Olga Rajas, Felipe Rodriguez de Castro, Jose Blanquerand Antoni Torres6 Pathogen Directed Antimicrobial Treatment of PneumoniaSantiago Ewig and Soren Gatermann7 General Pharmacological Considerations in Antibiotic Treatment of Community-Acquired PneumoniaFrancesco Blasi, Mario Cazzola and Paolo Tarsia8 beta -Lactams in the Therapy of Community-Acquired PneumoniaMichael S. Niederman9 Macrolides and KetolidesJavier Garau10 Role of Fluoroquinolones in the Treatment of Community-Acquired PneumoniaTobias Welte11 Non-Responding PneumoniaRosario Menendez12 Influenza and Pneumococcal Vaccination for Prevention of Community-Acquired Pneumonia in Immunocompetent Adults ke Ortqvist13 Adjunctive Therapy in Community-Acquired PneumoniaAnna P. Lam and Richard G. WunderinkIndex